Clinical Trial Update: Levosimendan in Congenital Cardiac Surgery [NA]

View source ↗

Summary

A completed clinical trial evaluating the use of levosimendan in congenital heart surgery for congenital heart defects and low cardiac output syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects
• Low Cardiac Output Syndrome

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Congenital Cardiovascular Defects, Low Cardiac Output Syndrome | NA | Status: COMPLETED